Cargando…

Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2

BACKGROUND: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jereczek-Fossa, Barbara Alicja, Pepa, Matteo, Marvaso, Giulia, Isaksson, Johannes Lars, Soatti, Carlo Pietro, Cazzaniga, Luigi Franco, Ivaldi, Giovanni Battista, Amadori, Marcello, Antognoni, Paolo, Arcangeli, Stefano, Buffoli, Alberto, Beltramo, Giancarlo, Bignardi, Mario, Bracelli, Stefano, Bruschieri, Lorenza, Castiglioni, Simona, Catalano, Gianpiero, Di Muzio, Nadia, Fallai, Carlo, Fariselli, Laura, Filippi, Andrea Riccardo, Gramaglia, Alberto, Italia, Corrado, Lombardi, Fabrizio, Magrini, Stefano Maria, Nava, Simonetta, Orlandi, Ester, Pasinetti, Nadia, Sbicego, Elena Lara, Scandolaro, Luciano, Scorsetti, Marta, Stiglich, Francesco, Tortini, Roberto, Valdagni, Riccardo, Vavassori, Vittorio, Tonoli, Sandro, Palazzi, Mauro Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641253/
https://www.ncbi.nlm.nih.gov/pubmed/33150476
http://dx.doi.org/10.1007/s12032-020-01434-1
_version_ 1783605881122848768
author Jereczek-Fossa, Barbara Alicja
Pepa, Matteo
Marvaso, Giulia
Isaksson, Johannes Lars
Soatti, Carlo Pietro
Cazzaniga, Luigi Franco
Ivaldi, Giovanni Battista
Amadori, Marcello
Antognoni, Paolo
Arcangeli, Stefano
Buffoli, Alberto
Beltramo, Giancarlo
Bignardi, Mario
Bracelli, Stefano
Bruschieri, Lorenza
Castiglioni, Simona
Catalano, Gianpiero
Di Muzio, Nadia
Fallai, Carlo
Fariselli, Laura
Filippi, Andrea Riccardo
Gramaglia, Alberto
Italia, Corrado
Lombardi, Fabrizio
Magrini, Stefano Maria
Nava, Simonetta
Orlandi, Ester
Pasinetti, Nadia
Sbicego, Elena Lara
Scandolaro, Luciano
Scorsetti, Marta
Stiglich, Francesco
Tortini, Roberto
Valdagni, Riccardo
Vavassori, Vittorio
Tonoli, Sandro
Palazzi, Mauro Filippo
author_facet Jereczek-Fossa, Barbara Alicja
Pepa, Matteo
Marvaso, Giulia
Isaksson, Johannes Lars
Soatti, Carlo Pietro
Cazzaniga, Luigi Franco
Ivaldi, Giovanni Battista
Amadori, Marcello
Antognoni, Paolo
Arcangeli, Stefano
Buffoli, Alberto
Beltramo, Giancarlo
Bignardi, Mario
Bracelli, Stefano
Bruschieri, Lorenza
Castiglioni, Simona
Catalano, Gianpiero
Di Muzio, Nadia
Fallai, Carlo
Fariselli, Laura
Filippi, Andrea Riccardo
Gramaglia, Alberto
Italia, Corrado
Lombardi, Fabrizio
Magrini, Stefano Maria
Nava, Simonetta
Orlandi, Ester
Pasinetti, Nadia
Sbicego, Elena Lara
Scandolaro, Luciano
Scorsetti, Marta
Stiglich, Francesco
Tortini, Roberto
Valdagni, Riccardo
Vavassori, Vittorio
Tonoli, Sandro
Palazzi, Mauro Filippo
author_sort Jereczek-Fossa, Barbara Alicja
collection PubMed
description BACKGROUND: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. MATERIALS AND METHODS: A questionnaire dealing with the management of pandemic was developed online and sent to all CODRAL Directors on the 10th of June 2020. Answers were collected in full anonymity one week after. RESULTS: All the 33 contacted RT facilities (100%) responded to the survey. Despite the scale of the pandemic, during P1 14 (42.4%) centres managed to safely continue the activity (≤ 10% reduction). During P2, 10 (30.3%) centres fully recovered and 14 (42.4%) reported an increase. Nonetheless, 6 (18.2%) declared no changes and, interestingly, 3 (9.1%) reduced activities. Overall, 21 centres (63.6%) reported suspected or positive cases within healthcare workforce since the beginning of the pandemic. Staff units were quarantined in 19 (57.6%) and 6 (18.2%) centres throughout P1 and P2, respectively. In the two phases, about two thirds centres registered positive or suspected cases amongst patients. CONCLUSION: The study revealed a particular attention to anti-contagion measures and a return to normal or even higher clinical workload in most RT centres in Lombardy, necessary to carry out current and previously deferred treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12032-020-01434-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7641253
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-76412532020-11-05 Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 Jereczek-Fossa, Barbara Alicja Pepa, Matteo Marvaso, Giulia Isaksson, Johannes Lars Soatti, Carlo Pietro Cazzaniga, Luigi Franco Ivaldi, Giovanni Battista Amadori, Marcello Antognoni, Paolo Arcangeli, Stefano Buffoli, Alberto Beltramo, Giancarlo Bignardi, Mario Bracelli, Stefano Bruschieri, Lorenza Castiglioni, Simona Catalano, Gianpiero Di Muzio, Nadia Fallai, Carlo Fariselli, Laura Filippi, Andrea Riccardo Gramaglia, Alberto Italia, Corrado Lombardi, Fabrizio Magrini, Stefano Maria Nava, Simonetta Orlandi, Ester Pasinetti, Nadia Sbicego, Elena Lara Scandolaro, Luciano Scorsetti, Marta Stiglich, Francesco Tortini, Roberto Valdagni, Riccardo Vavassori, Vittorio Tonoli, Sandro Palazzi, Mauro Filippo Med Oncol Original Paper BACKGROUND: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. MATERIALS AND METHODS: A questionnaire dealing with the management of pandemic was developed online and sent to all CODRAL Directors on the 10th of June 2020. Answers were collected in full anonymity one week after. RESULTS: All the 33 contacted RT facilities (100%) responded to the survey. Despite the scale of the pandemic, during P1 14 (42.4%) centres managed to safely continue the activity (≤ 10% reduction). During P2, 10 (30.3%) centres fully recovered and 14 (42.4%) reported an increase. Nonetheless, 6 (18.2%) declared no changes and, interestingly, 3 (9.1%) reduced activities. Overall, 21 centres (63.6%) reported suspected or positive cases within healthcare workforce since the beginning of the pandemic. Staff units were quarantined in 19 (57.6%) and 6 (18.2%) centres throughout P1 and P2, respectively. In the two phases, about two thirds centres registered positive or suspected cases amongst patients. CONCLUSION: The study revealed a particular attention to anti-contagion measures and a return to normal or even higher clinical workload in most RT centres in Lombardy, necessary to carry out current and previously deferred treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12032-020-01434-1) contains supplementary material, which is available to authorized users. Springer US 2020-11-04 2020 /pmc/articles/PMC7641253/ /pubmed/33150476 http://dx.doi.org/10.1007/s12032-020-01434-1 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Jereczek-Fossa, Barbara Alicja
Pepa, Matteo
Marvaso, Giulia
Isaksson, Johannes Lars
Soatti, Carlo Pietro
Cazzaniga, Luigi Franco
Ivaldi, Giovanni Battista
Amadori, Marcello
Antognoni, Paolo
Arcangeli, Stefano
Buffoli, Alberto
Beltramo, Giancarlo
Bignardi, Mario
Bracelli, Stefano
Bruschieri, Lorenza
Castiglioni, Simona
Catalano, Gianpiero
Di Muzio, Nadia
Fallai, Carlo
Fariselli, Laura
Filippi, Andrea Riccardo
Gramaglia, Alberto
Italia, Corrado
Lombardi, Fabrizio
Magrini, Stefano Maria
Nava, Simonetta
Orlandi, Ester
Pasinetti, Nadia
Sbicego, Elena Lara
Scandolaro, Luciano
Scorsetti, Marta
Stiglich, Francesco
Tortini, Roberto
Valdagni, Riccardo
Vavassori, Vittorio
Tonoli, Sandro
Palazzi, Mauro Filippo
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
title Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
title_full Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
title_fullStr Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
title_full_unstemmed Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
title_short Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
title_sort back to (new) normality—a codral/airo-l survey on cancer radiotherapy in lombardy during italian covid-19 phase 2
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641253/
https://www.ncbi.nlm.nih.gov/pubmed/33150476
http://dx.doi.org/10.1007/s12032-020-01434-1
work_keys_str_mv AT jereczekfossabarbaraalicja backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT pepamatteo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT marvasogiulia backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT isakssonjohanneslars backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT soatticarlopietro backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT cazzanigaluigifranco backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT ivaldigiovannibattista backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT amadorimarcello backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT antognonipaolo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT arcangelistefano backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT buffolialberto backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT beltramogiancarlo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT bignardimario backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT bracellistefano backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT bruschierilorenza backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT castiglionisimona backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT catalanogianpiero backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT dimuzionadia backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT fallaicarlo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT farisellilaura backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT filippiandreariccardo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT gramagliaalberto backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT italiacorrado backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT lombardifabrizio backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT magrinistefanomaria backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT navasimonetta backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT orlandiester backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT pasinettinadia backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT sbicegoelenalara backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT scandolaroluciano backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT scorsettimarta backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT stiglichfrancesco backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT tortiniroberto backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT valdagniriccardo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT vavassorivittorio backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT tonolisandro backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT palazzimaurofilippo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2
AT backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2